| Financial Year |
March 31 2023 |
| Monetary Funds |
5,737,166,577.91 |
| Held-for-trading Financial Assets |
2,209,796,337.00 |
| Notes Receivable |
682,640,861.08 |
| Accounts Receivable |
1,616,860,067.25 |
| Advances to Suppliers |
173,579,650.69 |
| Other Receivables |
95,371,929.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,527,411,635.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
526,356.76 |
| Total Current Assets |
12,043,353,415.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,227,805.58 |
| Investment Properties |
61,375,342.15 |
| Fixed Assetes |
1,641,667,146.44 |
| Under-construction Projects |
391,705,625.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
217,982,009.79 |
| R&D expenses |
-- |
| Goodwill |
60,573,832.56 |
| Long-Term Deferred and Prepaid Expenses |
5,834,322.27 |
| Deferred Income Tax Assets |
380,344,520.95 |
| Other Non-Current Assets |
57,333,524.81 |
| Sub-Total of Non-Current Assets |
2,843,039,875.82 |
| Total Assets |
14,886,393,291.48 |
| Short-Term Loans |
72,865,891.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
840,386,677.81 |
| Accounts Payable |
2,107,196,027.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,919,563.11 |
| Taxes Payable |
204,029,124.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
277,703,667.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,671,571.33 |
| Other Current Liabilities |
106,145,513.51 |
| Sub-Total of Current Liabilities |
4,478,795,501.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,750,200.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
160,287,449.45 |
| Total Liabilities |
4,639,082,951.23 |
| Paid-In Capital(Or Share Stock) |
949,024,050.00 |
| Capital Surplus |
412,100,221.43 |
| Surplus Reserve |
474,516,412.50 |
| LESS:Treasury Stock |
199,995,742.59 |
| Undistributed Profits |
8,587,813,156.93 |
| Minority Stockholder's Interest |
124,009,876.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,123,300,464.11 |
| Owner's Equity（Stockholder's Equity） |
10,247,310,340.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,886,393,291.48 |
